2013.11.26 | Tina Christensen
Department of Clinical Epidemiology is part of the consortium behind the project “Accelerated Development of Vaccine benefit-risk Collaboration in Europe” (ADVANCE). The project is financed by a grant of EUR 5 million from the IMI (The Innovative Medicines Initiative) and has a total budget of EUR 10.7 million. ADVANCE is coordinated by professor Miriam Sturkenboom from the Erasmus Universitair Medisch Centrum in the Netherlands and is carried out by a consortium of 27 organisations.
Read more about ADVANCE here: www.imi.europa.eu/content/advance